Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715073 · ClinicalTrials.gov registry record · NA
Improving Cognition With Neurodegradation Countermeasure
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05715073 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 23 participants.
The verdict
NCT05715073, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The goal of this randomized, placebo-controlled, three-condition, double-blind, within-participants crossover clinical trial is to compare caffeine, TeaCrine plus caffeine, and a placebo condition in ROTC or tactical personnel. The main question it aims to answer is the effect of the condition on measures of cognitive performance, cardio-autonomic, and hemodynamic responses after a physically demanding protocol. The physiological function will be derived from metrics of heart rate variability, whilst cogntive performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory. Participants will report to the lab 4 times, once for familiarization of cognitive measures and then 3 times for their experimental visits. Participants will consume their randomized condition an hour prior to the fatiguing interval exercise protocol. Following they will complete a series of cognitive tasks.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Caffeine
- DIETARY_SUPPLEMENT TeaCrine and Caffeine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05715073
The ClinicalTrials.gov registry entry for NCT05715073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT05715073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05715073 about?
NCT05715073 is a clinical study titled "Improving Cognition With Neurodegradation Countermeasure". The goal of this randomized, placebo-controlled, three-condition, double-blind, within-participants crossover clinical trial is to compare caffeine, TeaCrine plus caffeine, and a placebo condition in ROTC or tactical personnel. The main question it aims to answer is the effect of the condition on m...
What is the current status of trial NCT05715073?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2023-03-01. Estimated completion is 2023-11-01.
What interventions are being tested in trial NCT05715073?
The interventions under investigation include: Placebo (OTHER), Caffeine (DIETARY_SUPPLEMENT), TeaCrine and Caffeine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05715073?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.